Lifestyle changes and mazdutide injection for weight loss
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether combining lifestyle changes (diet and exercise) with a medication called mazdutide can help adults with obesity lose weight and keep it off. Mazdutide is an injectable medication that may help reduce appetite and support weight management over 2 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your BMI (body mass index, a measure of weight relative to height) is between 28.0 and 45.0
- You do not have diabetes or take diabetes medications
- You have not had major heart problems, stroke, or chest pain in the past 6 months
- You are not a current smoker and have not smoked regularly in the past 3 months
- You can commit to follow-up visits over 2 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether mazdutide, a medication that may help reduce fat in organs and aid weight loss, can reduce fat build-up in the pancreas for people who are overweight or obese. It might help improve metabolic health and reduce risks related to fatty pancreas.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
This study tests a medicine called tirzepatide to see if it helps people with overweight or obesity lose weight, whether or not they also have type 2 diabetes. Tirzepatide is given as an injection and works on hormones that control appetite.
This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.
This study tests whether mazdutide, a medicine that may help with weight and blood sugar, can reduce plaque buildup in the heart's arteries. It is for people who are overweight or obese and have some narrowing in their heart arteries but do not need immediate procedures like stents.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.